Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 2
1990 2
1991 2
1992 1
1993 3
1994 2
1995 3
1996 2
1997 2
1998 1
2000 3
2001 3
2002 3
2006 1
2009 1
2010 1
2011 6
2012 13
2013 9
2014 17
2015 15
2016 11
2017 11
2018 14
2019 11
2020 20
2021 26
2022 33
2023 35
2024 32

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

266 results

Results by year

Filters applied: . Clear all
Page 1
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts.
Bhatt SP, Rabe KF, Hanania NA, Vogelmeier CF, Cole J, Bafadhel M, Christenson SA, Papi A, Singh D, Laws E, Mannent LP, Patel N, Staudinger HW, Yancopoulos GD, Mortensen ER, Akinlade B, Maloney J, Lu X, Bauer D, Bansal A, Robinson LB, Abdulai RM; BOREAS Investigators. Bhatt SP, et al. N Engl J Med. 2023 Jul 20;389(3):205-214. doi: 10.1056/NEJMoa2303951. Epub 2023 May 21. N Engl J Med. 2023. PMID: 37272521 Clinical Trial.
Treatable traits in the NOVELTY study.
Agustí A, Rapsomaniki E, Beasley R, Hughes R, Müllerová H, Papi A, Pavord ID, van den Berge M, Faner R; NOVELTY Study Investigators. Agustí A, et al. Respirology. 2022 Nov;27(11):929-940. doi: 10.1111/resp.14325. Epub 2022 Jul 21. Respirology. 2022. PMID: 35861464 Free PMC article.
Pulmonary infections with nontuberculous mycobacteria.
Pedersen AA, Dahl VN, Hilberg O, Løkke A, Fløe A. Pedersen AA, et al. Among authors: hilberg o. Ugeskr Laeger. 2024 Apr 1;186(14):V06230603. doi: 10.61409/V06230603. Ugeskr Laeger. 2024. PMID: 38606709 Free article. Review. Danish.
[Sarcoidosis].
Møller J, Hellmund V, Hilberg O, Løkke A. Møller J, et al. Among authors: hilberg o. Ugeskr Laeger. 2018 Aug 20;180(34):V10170777. Ugeskr Laeger. 2018. PMID: 30152318 Free article. Review. Danish.
Clinical Response and Remission in Patients With Severe Asthma Treated With Biologic Therapies.
Hansen S, Baastrup Søndergaard M, von Bülow A, Bjerrum AS, Schmid J, Rasmussen LM, Johnsen CR, Ingebrigtsen T, Håkansson KEJ, Johansson SL, Bisgaard M, Assing KD, Hilberg O, Ulrik C, Porsbjerg C. Hansen S, et al. Among authors: hilberg o. Chest. 2024 Feb;165(2):253-266. doi: 10.1016/j.chest.2023.10.046. Epub 2023 Nov 3. Chest. 2024. PMID: 37925144 Free article.
[Bacterial lung abscesses].
Sperling S, Mortensen KL, Gjørup P, Fløe A, Hilberg O. Sperling S, et al. Among authors: hilberg o. Ugeskr Laeger. 2021 May 24;183(21):V12200948. Ugeskr Laeger. 2021. PMID: 34060466 Free article. Review. Danish.
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial.
Harrison TW, Chanez P, Menzella F, Canonica GW, Louis R, Cosio BG, Lugogo NL, Mohan A, Burden A, McDermott L, Garcia Gil E, Zangrilli JG; ANDHI study investigators. Harrison TW, et al. Lancet Respir Med. 2021 Mar;9(3):260-274. doi: 10.1016/S2213-2600(20)30414-8. Epub 2020 Dec 22. Lancet Respir Med. 2021. PMID: 33357499 Clinical Trial.
266 results